Skip to content

Latest

Consumer familiarity with retail clinics growing

Consumer familiarity with retail clinics growing

About one in five U.S. adults has visited a retail health clinic, up from roughly one in 10 six years ago, according to research by Kalorama Information. The health care market researcher said Monday that of 2,000 U.S. adults it surveyed online, 21.3% have gone to a retail clinic, a significant gain

Absorica capsules released by Ranbaxy

Ranbaxy Laboratories Inc. has announced the sales and promotion launch of Absorica capsules, a treatment for acne. The company said Monday that its Absorica Capsules (isotretinoin) are licensed from Cipher Pharmaceuticals Inc.

Stopain signs ex-NFL quarterback as spokesman

Troy Healthcare has signed former NFL quarterback Ron Jaworski as a national spokesman for its Stopain line of topical analgesics. The company said Monday that Jaworski, who played for the Philadelphia Eagles and now serves as an ESPN football analyst, is a natural ambassador for the Stopain brand.

CVS Caremark initiates offer to refinance debt

CVS Caremark Corp. has made cash tender offers to buy back up to $1 billion of senior notes. The company reported Monday that under the offers, it would purchase any and all of its $1 billion in 6.60% senior notes due 2019 and up to $1 billion of  its $2.45 billion in

Ranbaxy recalls generic Lipitor in U.S.

Ranbaxy Pharmaceuticals Inc. is voluntarily recalling select batches and dosages of atorvastatin calcium tablets, a generic version of the cholesterol-lowering drug Lipitor, in the United States. The drugmaker said on its website Friday that the recall is being conducted in the U.S.

Reckitt Benckiser inks deal to acquire Schiff

Reckitt Benckiser Group has signed an agreement to acquire Schiff Nutrition International Inc. in a $1.4 billion deal. The agreement comes less than a week after Reckitt Benckiser announced a tender offer to buy all of the outstanding shares of Schiff for $42 per share in cash.

Impax, Perrigo team on topical generic

Impax Laboratories Inc. has entered a collaboration with Perrigo Co. on a generic topical medication. Impax said Wednesday the development, manufacturing and commercialization agreement involves an "extended topical generic drug product" with "first to market potential.

IACP: FDA had authority to act against NECC

The International Academy of Compounding Pharmacists (IACP) has asked Food and Drug Administration Commissioner Margaret Hamburg to explain why the agency didn’t take specific actions to address complaints it had received about the New England Compounding Center (NECC), which federal officials say i